# Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia

> **NCT01481610** · PHASE2 · TERMINATED · sponsor: **Hospital Central Sur de Pemex** · enrollment: 28 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Arthralgia

## Interventions

- **DRUG:** Lumiracoxib
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT01481610
- **Lead sponsor:** Hospital Central Sur de Pemex
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Interim analysis shows harma to one of the study arms.
- **Last updated:** 2013-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481610, "Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01481610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*